Steven J. Mento - 10 Mar 2023 Form 4 Insider Report for Histogen Inc.

Role
President and CEO, Director
Signature
/s/ Susan A. Knudson as attorney-in-fact for Steven J. Mento, Ph.D.
Issuer symbol
N/A
Transactions as of
10 Mar 2023
Net transactions value
$0
Form type
4
Filing time
14 Mar 2023, 16:32:12 UTC
Previous filing
09 Nov 2022
Next filing
05 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTO Stock Option (right to buy) Award $0 +158,055 $0.000000 158,055 10 Mar 2023 Common Stock 158,055 $0.9500 Direct F1
transaction HSTO Stock Option (right to buy) Award $0 +55,532 $0.000000 55,532 10 Mar 2023 Common Stock 55,532 $0.9500 Direct F1, F2
transaction HSTO Stock Option (right to buy) Disposed to Issuer $0 -18,892 -100% $0.000000* 0 10 Mar 2023 Common Stock 18,892 $14.60 Direct F3, F4, F5
transaction HSTO Stock Option (right to buy) Disposed to Issuer $0 -7,582 -100% $0.000000* 0 10 Mar 2023 Common Stock 7,582 $5.40 Direct F3, F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vest one year after the date of grant, on 3/10/2024, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
F2 The shares subject to this option are subject to forfeiture in the event that the shares available pursuant to the Issuer's 2020 Incentive Award Plan are not increased prior to the one-year anniversary and vesting of the award by an amount required to be available for issuance for all outstanding stock awards containing this forfeiture condition.
F3 Effective June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share.
F4 On March 10, 2023, the Issuer and the Reporting Person agreed to cancel the stock option award.
F5 1/4 of the shares subject to the option vested one year after the date of grant, on 11/8/2022, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
F6 1/4 of the shares subject to the option vested one year after the date of grant, on 2/24/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.